As shown in the Figure 6A, we found that CHK1 depletion further sensitized the HeLa cells to MMC, implying that combined treatment with DNA crosslinking agents and CHK1 inhibitors might exhibit synergistic effects on cancer cell death. Here, CHEK1 is linked to cancer.